ProGenTech Raises $21 million

East meets West as ProGenTech, a research tools company based in China and the US, attracts new investors Bay City Capital and DT Capital.

In 2007, five Chinese health care companies, including WuXi PharmaTech Inc. and China Nepstar Drug Stores, went public on US Exchanges, raising nearly a billion dollars. That impressive performance has triggered a flood of interest among Western-based venture capitalists and hedge fund managers. To date, China-based contract research organizations have attracted the lion’s share of foreign investment, but recently other start-ups, including those with East/ West business models, are starting to command attention. (See "China: The Asian Dragon Lures Foreign Investors," START-UP, February 2008 Also see "China: The Asian Dragon Lures Foreign Investors" - Scrip, 1 February, 2008. and "China: The Wild, Wild East for Medical Devices," this issue Also see "China: The Wild, Wild East for Medical Devices" - Medtech Insight, 1 May, 2008..)GenturaDx is just the latest company to capitalize on the China buzz. In early April, the company announced its first round of institutional investing: a $21 million Series C led by Bay City Capital and DT Capital. [See Deal]

According to Fred Craves, managing partner at Bay City, the firm had been looking at investment opportunities in China for...

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on Medtech Insight for daily insights

  • Start your 7-day free trial
  • Explore trusted news, analysis, and insights
  • Access comprehensive global coverage
  • Enjoy instant access – no credit card required

More from Europe

Dxcover Launches US Operations With New Headquarters In Tennessee

 

Dxcover sets up new Clinical Laboratory Improvement Amendments (CLIA) lab in Franklin, Tennessee.

Fallouh Healthcare Receives Grant Funding From Innovate UK

 

Fallouh Healthcare has received £305,050 in grant funding from Innovate UK as part of the European Union’s Eureka Eurostars program. The company aims to detect cardiac tamponade, a condition that affects patients after heart surgery. Currently, there is no way to accurately diagnose the condition.

UK Trails NHS 10-Year Plan With Launch Imminent

 
• By 

Healthcare product industries await publication of the NHS 10-Year Plan, due out the coming days, which will focus on health generally not just the NHS, UK health secretary Wes Streeting said during a final prelaunch event on 24 June.

New EU Rules Limit Chinese Participation In Medtech Procurement

 

From June 30, new European Commission rules will attempt to redress an imbalance in medtech trade between the EU and the People’s Republic of China.

More from Geography

Fallouh Healthcare Receives Grant Funding From Innovate UK

 

Fallouh Healthcare has received £305,050 in grant funding from Innovate UK as part of the European Union’s Eureka Eurostars program. The company aims to detect cardiac tamponade, a condition that affects patients after heart surgery. Currently, there is no way to accurately diagnose the condition.

UK Trails NHS 10-Year Plan With Launch Imminent

 
• By 

Healthcare product industries await publication of the NHS 10-Year Plan, due out the coming days, which will focus on health generally not just the NHS, UK health secretary Wes Streeting said during a final prelaunch event on 24 June.

New EU Rules Limit Chinese Participation In Medtech Procurement

 

From June 30, new European Commission rules will attempt to redress an imbalance in medtech trade between the EU and the People’s Republic of China.